Anne-Marie Duff Will Be Lady Macbeth Opposite Ethan Hawke in Lincoln Center Theater's Macbeth

News   Anne-Marie Duff Will Be Lady Macbeth Opposite Ethan Hawke in Lincoln Center Theater's Macbeth
Lincoln Center Theater, which is under the direction of producing artistic director André Bishop, announced July 17 that Anne-Marie Duff will make her New York stage debut as Lady Macbeth opposite Ethan Hawke in its upcoming production of Shakespeare’s Macbeth.

Ethan Hawke
Ethan Hawke Photo by Joseph Marzullo/WENN

Directed by Tony winner Jack O'Brien, the production will begin performances Oct. 24 and open Nov. 21 at the Vivian Beaumont Theater.

Duff, who is currently starring in London in the National Theatre’s production of Strange Interlude, was nominated for an Olivier Award and won the London Critics Circle Award for her performance in the title role of St. Joan, also at the National. Her many other credits both at the National Theatre and in London’s West End include Collected Stories (Olivier Award nomination – Best Supporting Actress), King Lear, War and Peace, La Grande Magia and Vassa. She has starred on British television in "Elizabeth – The Virgin Queen" (BAFTA nomination – Best Actress), the series "Shameless" (BAFTA nomination – Best Actress), "Sinners" (Monte Carlo and Shanghai Film Festivals awards for Best Actress), "The Accused" and "Journey’s End." In film she was nominated for a British Independent Film Award for Best Actress and a BAFTA award for Best Supporting Actress for her role in "Nowhere Boy."

Additional casting will be announced at a later time.

Performances will be Tuesday-Saturday at 8 PM with matinees Wednesday and Saturday at 2 PM and Sunday at 2 PM. Beginning Nov. 26, all Tuesday evening performances will begin at 7 PM.

Tickets, priced from $75-$135, will be available beginning Aug. 25 at the Lincoln Center Theater box office, at or by visiting A limited number of tickets priced at $30 are available at every performance through LincTix, LCT’s program for 21-35 year olds. For information and to enroll, visit

Today’s Most Popular News: